Literature DB >> 16760016

Clearance of methotrexate by means of hemofiltration in a patient with osteosarcoma.

O M Escobosa Sánchez, A Herrero Hernández, M J Ortega Acosta, J Camacho Alonso, G Milano Manso, T Acha García.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16760016     DOI： 10.1007/s12094-006-0187-5

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  11 in total

1.  Methotrexate poisoning with acute hepatorenal dysfunction.

Authors:  E Goto; S Tomojiri; I Okamoto; K Tanaka
Journal:  J Toxicol Clin Toxicol       Date:  2001

2.  Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.

Authors:  B C Widemann; F M Balis; R F Murphy; J M Sorensen; M J Montello; M O'Brien; P C Adamson
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

Review 3.  Malignancy and renal disease.

Authors:  M Kapoor; G Z Chan
Journal:  Crit Care Clin       Date:  2001-07       Impact factor: 3.598

4.  Effective removal of methotrexate by high-flux hemodialysis.

Authors:  Jeffrey M Saland; Patrick J Leavey; Robert O Bash; Eleonora Hansch; Gerald S Arbus; Raymond Quigley
Journal:  Pediatr Nephrol       Date:  2002-08-09       Impact factor: 3.714

5.  Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid.

Authors:  B C Widemann; E Sung; L Anderson; W L Salzer; F M Balis; K S Monitjo; C McCully; M Hawkins; P C Adamson
Journal:  J Pharmacol Exp Ther       Date:  2000-09       Impact factor: 4.030

6.  Effective clearance of methotrexate using high-flux hemodialysis membranes.

Authors:  S M Wall; M J Johansen; D A Molony; T D DuBose; N Jaffe; T Madden
Journal:  Am J Kidney Dis       Date:  1996-12       Impact factor: 8.860

7.  Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapy.

Authors:  Anke S Krause; Martin R Weihrauch; Udo Bode; Gudrun Fleischhack; Thomas Elter; Theodor Heuer; Andreas Engert; Volker Diehl; Andreas Josting
Journal:  Leuk Lymphoma       Date:  2002-11

8.  Methotrexate removal during haemodialysis in a patient with advanced laryngeal carcinoma.

Authors:  A H Thomson; M Daly; J Knepil; P Harden; P Symonds
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

9.  Pharmacokinetic interaction between high-dose methotrexate and oxacillin.

Authors:  Karine Titier; Fabrice Lagrange; Fabienne Péhourcq; Nicholas Moore; Mathieu Molimard
Journal:  Ther Drug Monit       Date:  2002-08       Impact factor: 3.681

10.  High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.

Authors:  Brigitte C Widemann; Frank M Balis; Beate Kempf-Bielack; Stefan Bielack; Charles B Pratt; Stefano Ferrari; Gaetano Bacci; Alan W Craft; Peter C Adamson
Journal:  Cancer       Date:  2004-05-15       Impact factor: 6.860
View more
  1 in total

1.  Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.

Authors:  Marc Ghannoum; Darren M Roberts; David S Goldfarb; Jesper Heldrup; Kurt Anseeuw; Tais F Galvao; Thomas D Nolin; Robert S Hoffman; Valery Lavergne; Paul Meyers; Sophie Gosselin; Tudor Botnaru; Karine Mardini; David M Wood
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-02       Impact factor: 10.614
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.